Heron Therapeutics (HRTX) Tops Q3 EPS by 10c

Heron Therapeutics (NASDAQ: HRTX) reported Q3 EPS of ($0.51), $0.10 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $25.51 million.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies